You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 9, March 5, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Estrogen Replacement and Risk of Alzheimer Disease

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Zandi and colleagues1 found that HRT nonusers were significantly older than HRT users and had a 300% higher incidence of AD. Women with missing data on HRT use were even older than nonusers and had an additional 250% higher incidence of AD. Thus, it appears that these age differences were responsible for most of the increased incidence of AD. It is possible that at least some of the older women did not recall their HRT use simply because they were at the early stages of AD.

There may be other unmeasured selection biases among HRT users, who tend to be healthier than nonusers. Use of HRT is strongly associated with demographic and health-related factors.2 Initiation of HRT is associated with being encouraged by a physician and believing in the preventive efficacy of HRT.3 Many of these demographic, health issues, and prevention measures and beliefs are also . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
, , , , , , , and
JAMA. ;280():605-613.
FULL TEXT  

Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women: The Cache County Study
, , , , , , , and
JAMA. ;288():2123-2129.
FULL TEXT  

Hormone Therapy and Risk of Alzheimer Disease: A Critical Time
and
JAMA. ;288():2170-2172.
FULL TEXT  

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA. ;288():321-333.
FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
, , , and
JAMA. ;289():1100-1100.
FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
, , and
JAMA. ;289():1101-1101.
FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease

JAMA. ;289():1101-1101.
FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease--Reply
and
JAMA. ;289():1101-1102.
FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease--Reply
and
JAMA. ;289():1102-1102.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.